Full-Time

Vice President

Immunology Translational Medicine

Posted on 4/12/2024

Kymera Therapeutics

Kymera Therapeutics

201-500 employees

Develops small molecule protein degraders for diseases

Biotechnology

Senior, Expert

Belmont, MA, USA

Requirements
  • PhD, MD/PhD in Immunology or related discipline
  • Minimum of 15 years of relevant experience in preclinical and clinical immunology
  • Training/experience in clinical laboratory medicine preferred
  • Expertise in Immunology
  • Track record of translating molecular understanding of disease processes into clinical positioning
  • Experience in developing and implementing translational immunology assays in clinical trials
  • Experience in large and small company environments preferred
  • Strong communication skills with publications and presentations
  • Attention to detail in handling and analyzing experimental data
  • Excellent oral and written communication skills
  • Capability to collaborate, lead, and influence team members
  • Enthusiastic, goal-driven, creative, and self-aware
  • Equal opportunity employer
Responsibilities
  • Lead Translational Medicine efforts for Kymera’s I/I portfolio
  • Apply immunology biology and translational medicine experience to drive decision-making
  • Provide leadership to multiple drug discovery programs in immunology pipeline
  • Collaborate with stakeholders to define translational trial endpoints
  • Enable real-time analysis of clinical trial laboratory data
  • Direct efforts at Contract Research Organizations and Kymera’s labs
  • Build external relationships with scientific experts
  • Represent program team in discussions with management and stakeholders
  • Ensure progress to goals and manage priorities in a dynamic environment
  • Mentor and provide guidance to translational medicine project leads

Kymera Therapeutics is at the forefront of utilizing its proprietary Pegasus platform to develop small molecule protein degraders, targeting specific disease-causing proteins in critical areas like immunology-inflammation and oncology. This offers a dynamic workplace with a focus on cutting-edge technology and treatments that could drastically improve patient outcomes in significant disease domains. The company's commitment to advancing medical science and its technical proficiency provides a stimulating environment for professionals passionate about making a tangible impact on healthcare.

Company Stage

IPO

Total Funding

$879M

Headquarters

Watertown, Massachusetts

Founded

2016

Growth & Insights
Headcount

6 month growth

0%

1 year growth

7%

2 year growth

30%
INACTIVE